Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study

por Van Den Neste, Eric, Cazin, Bruno, Janssens, Ann, González-Barca, Eva, Terol, María José, Levy, Vincent, Pérez de Oteyza, Jaime, Zachee, Pierre, Saunders, Andrew, de Frias, Mercè, Campàs, Clara
Publicado 2012

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological...

por Baron, Frédéric, Zachée, Pierre, Maertens, Johan, Kerre, Tessa, Ory, Aurélie, Seidel, Laurence, Graux, Carlos, Lewalle, Philippe, Van Gelder, Michel, Theunissen, Koen, Willems, Evelyne, Emonds, Marie-Paule, De Becker, Ann, Beguin, Yves
Publicado 2015

Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study

por Servais, Sophie, Baron, Frédéric, Lechanteur, Chantal, Seidel, Laurence, Selleslag, Dominik, Maertens, Johan, Baudoux, Etienne, Zachee, Pierre, Van Gelder, Michel, Noens, Lucien, Kerre, Tessa, Lewalle, Philippe, Schroyens, Wilfried, Ory, Aurélie, Beguin, Yves
Publicado 2018

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis

por Servais, Sophie, Baron, Frédéric, Lechanteur, Chantal, Seidel, Laurence, Baudoux, Etienne, Briquet, Alexandra, Selleslag, Dominik, Maertens, Johan, Poire, Xavier, Schroyens, Wilfried, Graux, Carlos, De Becker, Ann, Zachee, Pierre, Ory, Aurélie, Herman, Julie, Kerre, Tessa, Beguin, Yves
Publicado 2023

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom...

por Mesa, Ruben, Vannucchi, Alessandro M., Yacoub, Abdulraheem, Zachee, Pierre, Garg, Mamta, Lyons, Roger, Koschmieder, Steffen, Rinaldi, Ciro, Byrne, Jennifer, Hasan, Yasmin, Passamonti, Francesco, Verstovsek, Srdan, Hunter, Deborah, Jones, Mark M., Zhen, Huiling, Habr, Dany, Martino, Bruno
Publicado 2016

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

por Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Publicado 2021

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

por Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Publicado 2021

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

por Stadtmauer, Edward A., Sullivan, Keith M., El Idrissi, Mohamed, Salaun, Bruno, Alonso Alonso, Aránzazu, Andreadis, Charalambos, Anttila, Veli-Jukka, Bloor, Adrian JC, Broady, Raewyn, Cellini, Claudia, Cuneo, Antonio, Dagnew, Alemnew F., Di Paolo, Emmanuel, Eom, HyeonSeok, González-Rodríguez, Ana Pilar, Grigg, Andrew, Guenther, Andreas, Heineman, Thomas C., Jarque, Isidro, Kwak, Jae-Yong, Lucchesi, Alessandro, Oostvogels, Lidia, Polo Zarzuela, Marta, Schuind, Anne E., Shea, Thomas C., Sinisalo, Ulla Marjatta, Vural, Filiz, Yáñez San Segundo, Lucrecia, Zachée, Pierre, Bastidas, Adriana
Publicado 2021